Wells Fargo’s Adial Pharmaceuticals ADIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48 | Hold |
160
| – | – | ﹤0.01% | 6124 |
|
|
2025
Q1 | $101 | Hold |
160
| – | – | ﹤0.01% | 5905 |
|
|
2024
Q4 | $162 | Buy |
+160
| New | +$162 | ﹤0.01% | 5879 |
|
|
2024
Q2 | – | Sell |
-11
| Closed | -$15 | – | 6481 |
|
|
2024
Q1 | $15 | Buy |
11
+3
| +38% | +$4 | ﹤0.01% | 6799 |
|
|
2023
Q4 | $15 | Hold |
8
| – | – | ﹤0.01% | 6842 |
|
|
2023
Q3 | $22 | Buy |
8
+1
| +14% | +$3 | ﹤0.01% | 6786 |
|
|
2023
Q2 | $39 | Sell |
7
-30
| -81% | -$167 | ﹤0.01% | 6805 |
|
|
2023
Q1 | $322 | Hold |
37
| – | – | ﹤0.01% | 6323 |
|
|
2022
Q4 | $197 | Sell |
37
-3
| -8% | -$16 | ﹤0.01% | 6296 |
|
|
2022
Q3 | $0 | Hold |
40
| – | – | ﹤0.01% | 6254 |
|
|
2022
Q2 | $1K | Buy |
40
+1
| +3% | +$25 | ﹤0.01% | 6148 |
|
|
2022
Q1 | $2K | Buy |
39
+4
| +11% | +$205 | ﹤0.01% | 6286 |
|
|
2021
Q4 | $2K | Hold |
35
| – | – | ﹤0.01% | 6299 |
|
|
2021
Q3 | $3K | Buy |
35
+2
| +6% | +$171 | ﹤0.01% | 6145 |
|
|
2021
Q2 | $2K | Buy |
33
+1
| +3% | +$61 | ﹤0.01% | 6178 |
|
|
2021
Q1 | $2K | Hold |
32
| – | – | ﹤0.01% | 6245 |
|
|
2020
Q4 | $1K | Hold |
32
| – | – | ﹤0.01% | 5983 |
|
|
2020
Q3 | $2K | Hold |
32
| – | – | ﹤0.01% | 5770 |
|
|
2020
Q2 | $1K | Hold |
32
| – | – | ﹤0.01% | 5762 |
|
|
2020
Q1 | $1K | Buy |
32
+2
| +7% | +$63 | ﹤0.01% | 5706 |
|
|
2019
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 5742 |
|
|
2019
Q3 | $1K | Buy |
30
+4
| +15% | +$133 | ﹤0.01% | 5781 |
|
|
2019
Q2 | $1K | Hold |
26
| – | – | ﹤0.01% | 5761 |
|
|
2019
Q1 | $2K | Buy |
26
+16
| +160% | +$1.23K | ﹤0.01% | 5689 |
|
|
2018
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 5773 |
|